Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
6 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
S100A8/A9 predicts response to PIM kinase and PD-1/PD-L1 inhibition in triple-negative breast cancer mouse models.
Commun Med (Lond). 2024 Feb 20;4(1):22. doi: 10.1038/s43856-024-00444-8.
Commun Med (Lond). 2024.
PMID: 38378783
Free PMC article.
Synergistic PIM kinase and proteasome inhibition as a therapeutic strategy for MYC-overexpressing triple-negative breast cancer.
Kunder R, Velyunskiy M, Dunne SF, Cho BK, Kanojia D, Begg L, Orriols AM, Fleming-Trujillo E, Vadlamani P, Vialichka A, Bolin R, Perrino JN, Roth D, Clutter MR, Zielinski-Mozny NA, Goo YA, Cristofanilli M, Mendillo ML, Vassilopoulos A, Horiuchi D.
Kunder R, et al. Among authors: zielinski mozny na.
Cell Chem Biol. 2022 Mar 17;29(3):358-372.e5. doi: 10.1016/j.chembiol.2021.08.011. Epub 2021 Sep 14.
Cell Chem Biol. 2022.
PMID: 34525344
Free PMC article.
Item in Clipboard
Response to Protocol Review Scenario: pilot study.
Levin SI, Zielinski Mozny NA.
Levin SI, et al. Among authors: zielinski mozny na.
Lab Anim (NY). 2013 Feb;42(2):49-50. doi: 10.1038/laban.215.
Lab Anim (NY). 2013.
PMID: 23340783
No abstract available.
Item in Clipboard
S100A8/A9 predicts triple-negative breast cancer response to PIM kinase and PD-1/PD-L1 inhibition.
Begg LR, Orriols AM, Zannikou M, Yeh C, Vadlamani P, Kanojia D, Bolin R, Dunne SF, Balakrishnan S, Camarda R, Roth D, Zielinski-Mozny NA, Yau C, Vassilopoulos A, Huang TH, Kim KA, Horiuchi D.
Begg LR, et al. Among authors: zielinski mozny na.
bioRxiv [Preprint]. 2023 Sep 23:2023.09.21.558870. doi: 10.1101/2023.09.21.558870.
bioRxiv. 2023.
PMID: 37790346
Free PMC article.
Updated.
Preprint.
Item in Clipboard
Biological activity of A-289099: an orally active tubulin-binding indolyloxazoline derivative.
Tahir SK, Nukkala MA, Zielinski Mozny NA, Credo RB, Warner RB, Li Q, Woods KW, Claiborne A, Gwaltney SL 2nd, Frost DJ, Sham HL, Rosenberg SH, Ng SC.
Tahir SK, et al. Among authors: zielinski mozny na.
Mol Cancer Ther. 2003 Mar;2(3):227-33.
Mol Cancer Ther. 2003.
PMID: 12657717
Item in Clipboard
Effect of vfr mutation on global gene expression and catabolite repression control of Pseudomonas aeruginosa.
Suh SJ, Runyen-Janecky LJ, Maleniak TC, Hager P, MacGregor CH, Zielinski-Mozny NA, Phibbs PV, West SEH.
Suh SJ, et al. Among authors: zielinski mozny na.
Microbiology (Reading). 2002 May;148(Pt 5):1561-1569. doi: 10.1099/00221287-148-5-1561.
Microbiology (Reading). 2002.
PMID: 11988531
Free article.
Item in Clipboard
Cite
Cite